Philips Settles US Sleep Apnea Claims for $1.1 Billion bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Philips will allocate $1.1 billion to address the costs related to their sleep therapy devices in response to user concerns about the potential cancer risk linked to the product.
(Bloomberg) Royal Philips NV shares soared by a record after a lower-than-expected settlement on US claims linked to faulty sleep apnea devices, stoking hopes the manufacturer has moved past concerns that have dogged it for the past three years. Most Read from BloombergMusk Wins Tentative Clearance for Tesla Driving System in ChinaMusk Makes Surprise China Visit in Search of Tesla Revenue BoostElliott Built ‘Large’ Stake in Buffett-Favored Sumitomo, Source SaysYen Sparks Intervention Suspicio
Philips Halts Sale of Sleep Apnea Gear in US After FDA Deal bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.